CPhI Online is the largest global marketplace in the pharma ingredients industry
Cafosa Gum S.A.U
About Cafosa Gum S.A.U
Cafosa, a subsidiary of the MARS group, is the world's leading supplier of gum base, chewing gum's main ingredient. Cafosa dedicates its activity to the confectionery, nutraceutical and pharmaceutical industry.
Cafosa Health is a separate business unit dedicated specifically to the nutraceutical and pharmaceutical industry. Cafosa Health's vision is to develop the functional and medicated chewing gum category, as a friendly and efficient way to deliver health and wellness.
By functional chewing gum we mean an oral dosage form that can release an API (active pharmaceutical ingredient) or functional ingredient by the mechanical action of chewing. It presents great interest as an alternative and highly attractive delivery system for nutraceutical and pharmaceutical products.Chewing gum can be an optimal delivery system as it combines an attractive and enjoyable format with the effectiveness of the ingredient release and absorption.
Key facts about Cafosa Health:
-part of MARS group
-leaders in medicate...
Products from Cafosa Gum S.A.U
Cafosa Health, the business unit dedicated to the pharmaceutical and nutraceutical business offers you different solutions to launch functional and medicated gum, from product development to final production and also analytical, stability and clinical studies.
Depending on your necessities and specificities of your project we can go from accompanying you in all the phases of the development process, through to licensing our finished formulas or merely selling you the HiG® excipient.
Thanks to Health in Gum®, a directly compressible powder made using a gum base and sweeteners combination, we can produce compressed chewing gum with the desired APIs.
Why compressed gum?
-Because it lets you work with different APIs, which broadens the possibilities of products to develop.
-Because chewing gum is a pleasant product, which has better acceptance on behalf of the consumer.
-Because chewing gum can be an efficient drug delivery system due to time in mouth and oral release and absorption.
A friendly and efficient way to deliver health and wellness and to extend your product range and attract consumers.
Cafosa Oral Probiotic Gum is made with specific probiotic strains which act on oral flora, balancing the specific bacteria that can cause most common oral pathologies: gingivitis, inflammation, cavities and halitosis. Its effectiveness is supported by a clinical oral colonization study of AB-DENTALAC® through chewing.
AB-DENTALAC® patented strains count with in-vitro screening and pre-clinical studies for efficacy testing.
Chewing gum with benzocaine and chlorhexidine for the local symptomatic relief of mild infections of the mouth and throat combined with pain and no fever. Antiseptic action and analgesic properties.
Dossiers underway in various countries.
Position your company at the heart of the global Pharma industry with a CPhI Online membership
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
Generate high-quality, engaged leads for your business, all year round
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
Your company’s profile boosted at all participating CPhI events
An easy-to-use platform with a detailed dashboard showing your leads and performance